Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital

被引：0
|
作者：
Roeland, Eric [1 ]
Hwang, Michael [1 ]
机构：
[1] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
563
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management
    Bateni, Sarah B.
    Gingrich, Alicia A.
    Stewart, Susan L.
    Meyers, Frederick J.
    Bold, Richard J.
    Canter, Robert J.
    BMC CANCER, 2018, 18
  • [42] Expandable metal stents for the palliation of malignant colorectal obstruction. Report of 29 consecutive patients treated in a cancer hospital without emergency room
    De Bellis, Mario
    Rossi, Giovanni Battista
    Marone, Pietro
    Di Nardo, Giovanni
    Cesario, Stefania
    Sannino, Salvatore
    Tempesta, Alfonso
    GASTROINTESTINAL ENDOSCOPY, 2007, 65 (05) : AB267 - AB267
  • [43] Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management
    Sarah B. Bateni
    Alicia A. Gingrich
    Susan L. Stewart
    Frederick J. Meyers
    Richard J. Bold
    Robert J. Canter
    BMC Cancer, 18
  • [44] Nutritional Status as a Prognostic Factor for Survival in Palliative Care: A Retrospective Observational Analysis of Home Parenteral Nutrition in Cancer Patients with Inoperable Malignant Bowel Obstruction
    Tenderenda, Karolina
    Gierczak, Aleksandra
    Panczyk, Mariusz
    Sobocki, Jacek
    Zaczek, Zuzanna
    NUTRIENTS, 2024, 16 (11)
  • [45] Stent Versus Surgery: Determinants of Treatment Patterns in Elderly Stage IV Colorectal Cancer Patients With Malignant Bowel Obstruction
    Okafor, Philip N.
    Swanson, Kristi
    Shah, Nilay
    Talwalkar, Jayant A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S579 - S579
  • [46] Efficacy of Lanreotide 30 mg as Symptomatic Treatment in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis - a Randomized, Double-blind, Placebo-controlled Study
    Chauvenet, L.
    Mariani, P.
    Blumberg, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S223 - S223
  • [47] Efficacy of lanreotide 30 mg as symptomatic treatment in patients with inoperable bowel obstruction due to peritoneal carcinomatosis: A randomized double-blind, placebo-controlled study
    Mariani, P.
    Blumberg, J.
    Chauvenet, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [48] Retrospective review of the management of malignant bowel obstruction (MBO) in advanced cancer patients in an Australian acute tertiary referral hospital setting
    Manoharan, Sathya
    Chapman, Michael
    Davis, Alison
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 188 - 188
  • [49] A systematic review. with meta-analysis of survival, quality of life and cost-effectiveness of home parenteral nutrition in patients with inoperable malignant bowel obstruction
    Naghibi, M.
    Smith, T. R.
    Elia, M.
    CLINICAL NUTRITION, 2015, 34 (05) : 825 - 837
  • [50] Can we improve the management of inoperable malignant bowel obstruction? Results of a feasibility study of elemental diet as an alternative to parenteral nutrition in patients with advanced gynaecological cancer
    Allan, Lindsey L.
    Skene, Simon S.
    Eastley, Kate Bennett
    Herbertson, Rebecca
    Smith, Eleanor
    Michael, Agnieszka
    SUPPORTIVE CARE IN CANCER, 2024, 32 (08)
12345